{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:08:30Z","timestamp":1785812910637,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006722","name":"Centrum f\u00d6r Klinisk Forskning Dalarna","doi-asserted-by":"publisher","award":["CKFUU-105141"],"award-info":[{"award-number":["CKFUU-105141"]}],"id":[{"id":"10.13039\/501100006722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006722","name":"Centrum f\u00d6r Klinisk Forskning Dalarna","doi-asserted-by":"publisher","award":["CKFUU-374651"],"award-info":[{"award-number":["CKFUU-374651"]}],"id":[{"id":"10.13039\/501100006722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006722","name":"Centrum f\u00d6r Klinisk Forskning Dalarna","doi-asserted-by":"publisher","award":["CKFUU-566761"],"award-info":[{"award-number":["CKFUU-566761"]}],"id":[{"id":"10.13039\/501100006722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS-498901"],"award-info":[{"award-number":["SLS-498901"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS-93191"],"award-info":[{"award-number":["SLS-93191"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009230","name":"Landstinget i Uppsala l\u00e4n","doi-asserted-by":"publisher","award":["RFR-226161"],"award-info":[{"award-number":["RFR-226161"]}],"id":[{"id":"10.13039\/501100009230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009230","name":"Landstinget i Uppsala l\u00e4n","doi-asserted-by":"publisher","award":["RFR-462701"],"award-info":[{"award-number":["RFR-462701"]}],"id":[{"id":"10.13039\/501100009230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Lyme borreliosis (LB) is the most common tick-borne infection in Europe, with Lyme neuroborreliosis (LNB) its second most frequent clinical manifestation. Prognostic factors for clinical outcomes in LNB have not been identified. Elevated serum levels of the brain damage markers neuron-specific enolase (NSE) and S100 calcium-binding protein B (S100B) have been associated with poor clinical outcomes in other disorders of the central nervous system. The aim of this study is to assess NSE and S100B in serum as prognostic biomarkers for clinical outcomes in paediatric LNB patients. Children evaluated for LNB (<jats:italic>n<\/jats:italic>\u2009=\u2009121) in Sweden were prospectively included during 2010\u20132014, serum samples were collected on admission, and all children underwent a 2-month follow-up. Patients with pleocytosis and anti-<jats:italic>Borrelia<\/jats:italic> antibodies in cerebrospinal fluid (CSF) were classified as having LNB (<jats:italic>n<\/jats:italic>\u2009=\u200961). Controls were age- and gender-matched non-LNB patients (<jats:italic>n<\/jats:italic>\u2009=\u200960). NSE was elevated in 38\/61 (62%) LNB patients and in 31\/60 (52%) controls. S100B was elevated in 3\/60 (5%) LNB patients and 0\/59 (0%) controls. NSE and S100B concentrations did not differ significantly when comparing LNB patients with controls. No differences were found in the concentrations when comparing the clinical recovery of LNB patients at the 2-month follow-up. NSE was detectable in the majority of LNB patients and controls, whereas S100B was detectable in only a few LNB patients and no controls. NSE and S100B in serum cannot be recommended as prognostic biomarkers for clinical outcomes in children with LNB.<\/jats:p>","DOI":"10.1007\/s10096-022-04460-1","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T03:12:41Z","timestamp":1654485161000},"page":"1051-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis\u2014detection and evaluation as prognostic biomarkers for clinical outcome"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3258-427X","authenticated-orcid":false,"given":"Sigurdur","family":"Arnason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesia","family":"Molewijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9315-8901","authenticated-orcid":false,"given":"Anna J.","family":"Henningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-2496","authenticated-orcid":false,"given":"Ivar","family":"Tjernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-1554","authenticated-orcid":false,"given":"Barbro H.","family":"Skogman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"issue":"20","key":"4460_CR1","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJM199511163332004","volume":"333","author":"J Berglund","year":"1995","unstructured":"Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, Carlsson M, Runehagen A, Svanborg C, Norrby R (1995) An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333(20):1319\u20131327","journal-title":"N Engl J Med"},{"issue":"9396","key":"4460_CR2","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","volume":"362","author":"G Stanek","year":"2003","unstructured":"Stanek G, Strle F (2003) Lyme borreliosis. Lancet 362(9396):1639\u20131647","journal-title":"Lancet"},{"issue":"4","key":"4460_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1586\/eri.10.15","volume":"8","author":"D Tuerlinckx","year":"2010","unstructured":"Tuerlinckx D, Glupczynski Y (2010) Lyme neuroborreliosis in children. Expert Rev Anti Infect Ther 8(4):455\u2013463","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"4460_CR4","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/INF.0000000000001653","volume":"36","author":"L Sodermark","year":"2017","unstructured":"Sodermark L, Sigurdsson V, Nas W, Wall P, Trollfors B (2017) Neuroborreliosis in Swedish children: a population-based study on incidence and clinical characteristics. Pediatr Infect Dis J 36(11):1052\u20131056","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"4460_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, Lj\u00f8stad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(1):8\u201316 (e11-14)","journal-title":"Eur J Neurol"},{"issue":"6","key":"4460_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/00365540110080421","volume":"34","author":"J Berglund","year":"2002","unstructured":"Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H (2002) 5-y Follow-up study of patients with neuroborreliosis. Scand J Infect Dis 34(6):421\u2013425","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"4460_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","volume":"27","author":"BH Skogman","year":"2008","unstructured":"Skogman BH, Croner S, Nordwall M, Eknefelt M, Ernerudh J, Forsberg P (2008) Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J 27(12):1089\u20131094","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"4460_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1542\/peds.2011-3719","volume":"130","author":"BH Skogman","year":"2012","unstructured":"Skogman BH, Glimaker K, Nordwall M, Vrethem M, Odkvist L, Forsberg P (2012) Long-term clinical outcome after Lyme neuroborreliosis in childhood. Pediatrics 130(2):262\u2013269","journal-title":"Pediatrics"},{"issue":"2","key":"4460_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF01713316","volume":"24","author":"L Dotevall","year":"1996","unstructured":"Dotevall L, Rosengren LE, Hagberg L (1996) Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis. Infection 24(2):125\u2013129","journal-title":"Infection"},{"issue":"1","key":"4460_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12028-017-0414-7","volume":"28","author":"AK Au","year":"2018","unstructured":"Au AK, Bell MJ, Fink EL, Aneja RK, Kochanek PM, Clark RSB (2018) Brain-specific serum biomarkers predict neurological morbidity in diagnostically diverse pediatric intensive care unit patients. Neurocrit Care 28(1):26\u201334","journal-title":"Neurocrit Care"},{"issue":"12","key":"4460_CR11","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1089\/neu.2007.0316","volume":"24","author":"RP Berger","year":"2007","unstructured":"Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD (2007) Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 24(12):1793\u20131801","journal-title":"J Neurotrauma"},{"issue":"2","key":"4460_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00381-018-3955-y","volume":"35","author":"DW Park","year":"2019","unstructured":"Park DW, Park SH, Hwang SK (2019) Serial measurement of S100B and NSE in pediatric traumatic brain injury. Childs Nerv Syst 35(2):343\u2013348","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"4460_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.CCM.0000104116.91462.CD","volume":"32","author":"D Gazzolo","year":"2004","unstructured":"Gazzolo D, Marinoni E, Di Iorio R, Bruschettini M, Kornacka M, Lituania M, Majewska U, Serra G, Michetti F (2004) Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med 32(1):131\u2013136","journal-title":"Crit Care Med"},{"issue":"5","key":"4460_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1373\/clinchem.2003.021048","volume":"50","author":"D Gazzolo","year":"2004","unstructured":"Gazzolo D, Grutzfeld D, Michetti F, Toesca A, Lituania M, Bruschettini M, Dobrzanska A, Bruschettini P (2004) Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: relationship to brain damage and routine cerebrospinal fluid findings. Clin Chem 50(5):941\u2013944","journal-title":"Clin Chem"},{"issue":"4326","key":"4460_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1126\/science.339349","volume":"199","author":"D Schmechel","year":"1978","unstructured":"Schmechel D, Marangos PJ, Zis AP, Brightman M, Goodwin FK (1978) Brain endolases as specific markers of neuronal and glial cells. Science 199(4326):313\u2013315","journal-title":"Science"},{"issue":"2\u20133","key":"4460_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0009-8981(84)90295-X","volume":"136","author":"IN Day","year":"1984","unstructured":"Day IN, Thompson RJ (1984) Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and non-neuronal enolase, and 14-3-3 protein in circulating human blood cells. Clin Chim Acta 136(2\u20133):219\u2013228","journal-title":"Clin Chim Acta"},{"issue":"5","key":"4460_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1471-4159.1980.tb09967.x","volume":"34","author":"PJ Marangos","year":"1980","unstructured":"Marangos PJ, Campbell IC, Schmechel DE, Murphy DL, Goodwin FK (1980) Blood platelets contain a neuron-specific enolase subunit. J Neurochem 34(5):1254\u20131258","journal-title":"J Neurochem"},{"issue":"3","key":"4460_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0022-510X(83)90155-7","volume":"60","author":"K Mokuno","year":"1983","unstructured":"Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I (1983) Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 60(3):443\u2013451","journal-title":"J Neurol Sci"},{"key":"4460_CR19","first-page":"d1356","volume":"7","author":"CW Heizmann","year":"2002","unstructured":"Heizmann CW, Fritz G, Schafer BW (2002) S100 proteins: structure, functions and pathology. Front Biosci 7:d1356-1368","journal-title":"Front Biosci"},{"key":"4460_CR20","doi-asserted-by":"publisher","unstructured":"Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, Janigro D (2010) Extracranial sources of S100B do not affect serum levels. PLoS One 5(9):e12691.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0012691","DOI":"10.1371\/journal.pone.0012691"},{"issue":"6 Pt 1","key":"4460_CR21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/clinchem\/48.6.950","volume":"48","author":"LV Portela","year":"2002","unstructured":"Portela LV, Tort AB, Schaf DV, Ribeiro L, Nora DB, Walz R, Rotta LN, Silva CT, Busnello JV, Kapczinski F, Goncalves CA, Souza DO (2002) The serum S100B concentration is age dependent. Clin Chem 48(6 Pt 1):950\u2013952","journal-title":"Clin Chem"},{"issue":"5","key":"4460_CR22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1515\/cclm-2015-0771","volume":"54","author":"D Bouvier","year":"2016","unstructured":"Bouvier D, Duret T, Rouzaire P, Jabaudon M, Rouzaire M, Nourrisson C, Bourgne C, Pereira B, Evrard B, Sapin V (2016) Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays. Clin Chem Lab Med 54(5):833\u2013842","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"4460_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1373\/clinchem.2013.212472","volume":"60","author":"UK Rohlwink","year":"2014","unstructured":"Rohlwink UK, Figaji AA (2014) Biomarkers of brain injury in cerebral infections. Clin Chem 60(6):823\u2013834","journal-title":"Clin Chem"},{"issue":"1","key":"4460_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12887-018-1163-2","volume":"18","author":"K Backman","year":"2018","unstructured":"Backman K, Skogman BH (2018) Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study. BMC Pediatr 18(1):189\u2013189","journal-title":"BMC Pediatr"},{"issue":"9","key":"4460_CR25","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1212\/WNL.45.9.1663","volume":"45","author":"H Tumani","year":"1995","unstructured":"Tumani H, N\u00f6lker G, Reiber H (1995) Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45(9):1663\u20131670","journal-title":"Neurology"},{"issue":"2","key":"4460_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ana.410300212","volume":"30","author":"K Hansen","year":"1991","unstructured":"Hansen K, Lebech AM (1991) Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi\u2013specific immunoglobulin G, A, and M. Ann Neurol 30(2):197\u2013205","journal-title":"Ann Neurol"},{"issue":"1","key":"4460_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","volume":"17","author":"G Stanek","year":"2011","unstructured":"Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O\u2019Connell S, Ornstein K, Strle F, Gray J (2011) Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 17(1):69\u201379","journal-title":"Clin Microbiol Infect"},{"key":"4460_CR28","unstructured":"EDI\u2122 Human Neuron Specific Enolase ELISA Kit - manufacturers instructions., https:\/\/static1.squarespace.com\/static\/52545951e4b021818110f9cf\/t\/53cda1c7e4b076d747fc2a69\/1405985223422\/NSE+ELISA+CE_v7.pdf. Cited 2021\u201304\u201319 2021"},{"key":"4460_CR29","unstructured":"Laboratory instructions for neuronspecific enolase S., https:\/\/www.karolinska.se\/KUL\/Alla-anvisningar\/Anvisning\/9210. Cited 2020 May 6 2020"},{"key":"4460_CR30","unstructured":"Human soluble protein-100B (S-100B) ELISA Kit - manufacturers instructions., https:\/\/www.cusabio.com\/uploadfile\/Ins\/2018-01-23\/CSB-E08065h.pdf. Cited 2021\u201304\u201319 2021"},{"key":"4460_CR31","unstructured":"IDEIA immunossay - manufacturers instructions., https:\/\/www.thermofisher.com\/document-connect\/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FMBD%2FInstructions%2FX7840C.pdf&title=SURFSUEgTHltZSBOZXVyb2JvcnJlbGlvc2lz. Cited 2021\u201304\u201319 2021"},{"issue":"5","key":"4460_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/00365517709091496","volume":"37","author":"G Tibbling","year":"1977","unstructured":"Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37(5):385\u2013390","journal-title":"Scand J Clin Lab Invest"},{"issue":"11","key":"4460_CR33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s10096-017-3049-x","volume":"36","author":"BH Skogman","year":"2017","unstructured":"Skogman BH, Lager M, Henningsson AJ, Tjernberg I (2017) The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children. Eur J Clin Microbiol Infect Dis 36(11):2221\u20132229","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"4460_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1468-1331.1999.tb00010.x","volume":"6","author":"L Dotevall","year":"1999","unstructured":"Dotevall L, Hagberg L, Karlsson JE, Rosengren LE (1999) Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis. Eur J Neurol 6(2):169\u2013178","journal-title":"Eur J Neurol"},{"issue":"9","key":"4460_CR35","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1515\/CCLM.2008.262","volume":"46","author":"C Castellani","year":"2008","unstructured":"Castellani C, Stojakovic T, Cichocki M, Scharnagl H, Erwa W, Gutmann A, Weinberg A-M (2008) Reference ranges for neuroprotein S-100B: from infants to adolescents. Clin Chem Lab Med 46(9):1296\u20131299","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"4460_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.anpedi.2015.07.021","volume":"84","author":"M Arroyo Hern\u00e1ndez","year":"2016","unstructured":"Arroyo Hern\u00e1ndez M, Rodr\u00edguez Su\u00e1rez J, \u00c1lvarez Men\u00e9ndez F (2016) Serum S100\u03b2 protein reference values in a paediatric population. An Pediatr (Barcelona, Spain: 2003) 84(5):254\u2013259","journal-title":"An Pediatr (Barcelona, Spain: 2003)"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-022-04460-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T13:07:46Z","timestamp":1656767266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-022-04460-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4460"],"URL":"https:\/\/doi.org\/10.1007\/s10096-022-04460-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"25 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and was approved by the Regional Ethics Committee in Uppsala, Sweden (Dnr 2010\/106). Informed written consent was received from patients\/guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}